when were glp 1 drugs approved GLP-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response The first weight loss drugs
Description
doi:10.3390/nu11112611 Shi Q, Nong K, Vandvik PO, et al
The second study looked at 635 patients with type 2 diabetes who were also overweight or obese
However, no head-to-head comparisons of GLP-1RAs and other non-insulin glucose-lowering medications exist for patients with NAFLD and type 2 diabetes
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
GLP-1RAs may be viable for overweight or obese T1DM patients struggling to reach their blood sugar targets
The relevance to human therapy remains unclear (Nolte Kennedy & Masharani, 2015)
Biomed Res Int
